Drug intelligence / Profile preview

oxidized and regenerated cellulose

Development stage
Phase 4
Lead developer
Johnson & Johnson
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Surgical, Topical, Implant
01

Overview

Oxidized and regenerated cellulose is a plant-derived bioabsorbable hemostatic agent used in surgical procedures to control capillary, venous, and small arterial bleeding when conventional methods (such as ligation or cautery) are impractical or ineffective. It is produced by the partial oxidation of regenerated cellulose fibers. Upon application to a bleeding site during surgery, it forms a gelatinous mass that acts as a physical matrix for platelet adhesion and clot formation. The low pH of the material also promotes vasoconstriction and inhibits bacterial growth. The product is fully absorbable within several weeks post-implantation with minimal tissue reaction. It does not induce an immune response and can be left in situ after surgery[2][3][4][5][6]. Its primary mechanism of action is physical—providing a scaffold for clot formation—and chemical—lowering local pH to promote hemostasis.

Brand names
SURGICELSurgiGuardOxycelPahacelCuraCelSurgi-ORCTAGUM Regenerated Oxidized Cellulose
Other names
oxidized regenerated celluloseORC
02

Targets

MSR1 (Amyloid beta precursor protein binding family B member 3)

Beyond the preview

Go deeper on oxidized and regenerated cellulose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxidized and regenerated cellulose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call